Results 11 to 20 of about 16,540 (179)
Biomolecules & BiomedicineDipeptidyl peptidase-4 (DPP4) concentrations are known to correlate with nonalcoholic fatty liver (FL), which is also associated with subclinical atherosclerosis (SA).
Gilberto Vargas-Alarcón +6 more
doaj +3 more sources
Glucose metabolism disorders associated with COVID-19: clinical and morphological study
Сахарный диабет, 2023 BACKGROUND. Glucose metabolism disorders (GMD) were detected both in acute and in post-COVID, however, its pathogenic aspects remain unclear.AIM. To analyze the occurrence of GMD in post-COVID patients who have had moderate and severe COVID-19 without ...
T. L. Karonova +10 more
doaj +1 more source
Frontiers in Bioscience-Landmark, 2023 Background: Dipeptidyl peptidase-4 (DPP4) is a transmembrane glycoprotein, prevalent across a variety of tissues and cells and can be foundin a solubilised in peripheral blood.
Linqiao Li +8 more
doaj +1 more source
Reduced humidity induces skin barrier dysfunction and secretion of dipeptidyl peptidase-4 (DPP-4) in a skin-equivalent model [PDF]
Archives of Biological Sciences, 2019 Seasonal changes can affect the physiological condition of the skin and cause various cutaneous disorders. The skin barrier function tends to worsen during winter when humidity is lower compared to other seasons.
Lee Sung Hoon +4 more
doaj +1 more source
Boning up on DPP4, DPP4 substrates, and DPP4-adipokine interactions: Logical reasoning and known facts about bone related effects of DPP4 inhibitors [PDF]
Bone, 2016 Dipeptidyl peptidase 4 (DPP4) is a conserved exopeptidase with an important function in protein regulation. The activity of DPP4, an enzyme which can either be anchored to the plasma membrane or circulate free in the extracellular compartment, affects the glucose metabolism, cellular signaling, migration and differentiation, oxidative stress and the ...
Lorenzo Glorie +2 more
openaire +3 more sources
Jurnal Farmasi dan Ilmu Kefarmasian Indonesia, 2021 Background: Diabetes mellitus (DM) type 2 is a metabolic disorder that needs special attention because it can damage several organs if the severity increases. One of the treatments for diabetes mellitus (DM) type 2 is by inhibiting Dipeptidyl peptidase 4
Indah Permata Rendi +4 more
doaj +1 more source
Sitagliptin: a potential drug for the treatment of COVID-19?
Acta Pharmaceutica, 2021 Recently, an outbreak of a fatal coronavirus, SARS-CoV-2, has emerged from China and is rapidly spreading worldwide. Possible interaction of SARS-CoV-2 with DPP4 peptidase may partly contribute to the viral pathogenesis.
Bardaweel Sanaa K. +2 more
doaj +1 more source
A poor prognosis in human hepatocellular carcinoma is associated with low expression of DPP4 [PDF]
Brazilian Journal of Medical and Biological Research, 2020 This study aimed to explore the prognostic role of dipeptidyl peptidase 4 (DPP4) expression in hepatocellular carcinoma (HCC). DPP4 expression was measured in formalin-fixed paraffin-embedded specimens that were gathered from 327 HCC patients ...
Hao Yu +4 more
doaj +1 more source
Emerging Role of Dipeptidyl Peptidase-4 in Autoimmune Disease
Frontiers in Immunology, 2022 Dipeptidyl-peptidase IV (DPP4), originally identified as an aminopeptidase in 1960s, is an ubiquitously expressed protease presented as either a membrane-bound or soluble form.
Jie Huang +7 more
doaj +1 more source
DPP4 Is a Potential Prognostic Marker of Thyroid Carcinoma and a Target for Immunotherapy
International Journal of Endocrinology, 2022 DPP4 (dipeptidyl peptidase 4) is expressed in many cancers, but the relationship between DPP4 and thyroid carcinoma (THCA) is incompletely understood. We aim to explore the expression of DPP4 in THCA and the correlation between DPP4 expression with the ...
Xiaoqian Gao +5 more
doaj +1 more source